|
Volumn 23, Issue 1, 2017, Pages E5-E6
|
Efficacy of vedolizumab in patients with antibiotic and anti-tumor necrosis alpha refractory pouchitis
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
ANTIBIOTIC AGENT;
AZATHIOPRINE;
BUDESONIDE;
IMMUNOGLOBULIN;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
METHOTREXATE;
VEDOLIZUMAB;
GASTROINTESTINAL AGENT;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR;
ADULT;
CASE REPORT;
CLOSTRIDIUM DIFFICILE INFECTION;
COLON RESECTION;
DIARRHEA;
DRUG EFFICACY;
EDEMA;
FECAL MICROBIOTA TRANSPLANTATION;
FEMALE;
HUMAN;
HYPERBARIC OXYGEN THERAPY;
ILEITIS;
ILEUM POUCH;
INTESTINE ENDOSCOPY;
LETTER;
MALE;
MIDDLE AGED;
PRIORITY JOURNAL;
ULCER;
ULCERATIVE COLITIS;
ANTAGONISTS AND INHIBITORS;
ANTIBIOTIC RESISTANCE;
PROCTOCOLECTOMY;
ANTIBODIES, MONOCLONAL, HUMANIZED;
COLITIS, ULCERATIVE;
DRUG RESISTANCE, MICROBIAL;
FEMALE;
GASTROINTESTINAL AGENTS;
HUMANS;
MALE;
MIDDLE AGED;
POUCHITIS;
PROCTOCOLECTOMY, RESTORATIVE;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 85001976252
PISSN: 10780998
EISSN: 15364844
Source Type: Journal
DOI: 10.1097/MIB.0000000000000992 Document Type: Letter |
Times cited : (33)
|
References (3)
|